Bixiye
Northera® (droxidopa) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Dukumentiyadda & Foomamka Natiijooyinka
Soo bandhiga 1401 - 1410 ee natiijooyinka 3167
Bixiye
Homozygous Familial Hypercholesterolemia (HoFH) Agents - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Northera® (droxidopa) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Combination Non-Steroidal Anti-Inflammatory Drugs (NSAID) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Homozygous Familial Hypercholesterolemia (HoFH) Agents - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Imcivree™ (setmelanotide) - Commercial
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Cannabidiol - Medicaid
Prior Authorization
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Cannabidiol - Commercial
Prior Authorization
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
Samsca® (tolvaptan) - Medicaid
Prior Authorization, Quantity Limit
Taariikhda barnaamijka Dhaqangalayso Agosto 01, 2024
Bixiye
QP55R2-23 Change in Processing for Replacement Claims
Taariikhda dhaqangalka Barnaamijka: Jul 24, 2024